| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.8M | +104.2% |
| Cost of Revenue | $4.4M | +8.9% |
| R&D Expense | $25.0M | -24.4% |
| SG&A Expense | $27.6M | +11.6% |
| Operating Income | -$84.1M | +49.6% |
| Interest Expense | $2.2M | -18.3% |
| Pre-tax Income | -$76.7M | +62.6% |
| Income Tax | $44K | +158.8% |
| Net Income | -$76.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.8M | -64.2% |
| Accounts Receivable | $1.1M | -82.5% |
| Inventory | $5.4M | -29.9% |
| Current Assets | $12.7M | -57.9% |
| Total Assets | $25.2M | -40.8% |
| Current Liabilities | $93.8M | -31.8% |
| Total Liabilities | $97.0M | -31.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.4M | +52.0% |
| Capital Expenditures | $341K | -88.4% |
| Investing Cash Flow | -$341K | +87.3% |
| Financing Cash Flow | $61.9M | -31.7% |
| Free Cash Flow | -$70.8M | +52.7% |
| +62.6% |
| EPS (Basic) | -$1.34 | +15.2% |
| EPS (Diluted) | -$1.34 | +15.2% |
| Stockholders' Equity |
| -$71.8M |
| +31.2% |